Biotechnology company from Germany
Stefan Homburg: CDU Council invites Schwurbel professor to give a lecture: The CDU Economic Council invites you to a lecture with a professor who is notorious ...
t-online.de/nachrichten/deutschland/gesellschaft/id_100378778/stefan-homburg-cdu-rat-laedt-schwurbel-professor-zum-vortrag.html
Quick Glance: Stefan Homburg: Controversy Surrounding Lecture at Business Council
- The CDU's Business Council invites controversial Professor Stefan Homburg, known for spreading misinformation about Corona.
- Homburg, once a respected expert, faced criticism due to questionable statements during the pandemic.
- The decision to invite Homburg sparks outrage and criticism for his controversial views, especially upsetting cancer patients.
- The Business Council, a lobbying organization with ties to the CDU, faces scrutiny for organizing influential supporters and attracting backlash over the invitation.
Pfizer vs Moderna battle over COVID vaccine patents begins in UK: Pfizer and BioNTech asked a London court to revoke rival Moderna's patents over technology key ...
reuters.com/business/healthcare-pharmaceuticals/pfizer-vs-moderna-battle-over-covid-vaccine-patents-begins-uk-2024-04-23/
Mainz after the boom: Too many expenses and projects?: For two years, income in Mainz was bubbling. Now they are declining more than forecast ...
allgemeine-zeitung.de/lokales/mainz/stadt-mainz/mainz-nach-dem-boom-zu-viele-ausgaben-und-projekte-3405908
Vaccine: Biontech fuels hope in the fight against pancreatic cancer: The Mainz-based mRNA pioneer is working flat out on innovative therapies against cancer ...
faz.net/aktuell/wirtschaft/unternehmen/biontech-naehrt-hoffnung-im-kampf-gegen-bauchspeicheldruesenkrebs-19637578.html
Quick Glance: Vaccine: Biontech's Hopeful Fight Against Pancreatic Cancer
- Mainz-based mRNA pioneer works on innovative cancer treatments.
- New study data show potential for personalized cancer vaccines.
- Autogene Cevumeran triggers immune response in pancreatic cancer patients.
- Biontech aims to improve treatment standards in oncology with mRNA-based vaccines.
Pancreatic cancer: Biontech reports initial successes with “vaccination”: Activated “killer cells” are intended to destroy tumor foci and prevent relapse
nachrichten.at/meine-welt/gesundheit/biontech-meldet-erste-erfolge-bei-impfung-gegen-pankreaskrebs;art114,3938755
Quick Glance: Hopeful Results in Pancreatic Cancer Treatment
- Pancreatic cancer is among the most common cancers in Austria.
- Biontech reports success with new vaccine BNT122 against the cancer.
- Vaccine activates "killer cells" and prevents relapses.
- Surgical removal and chemotherapy improve survival chances.
Biontech: “Moderna has a one to two year lead when it comes to cancer drugs”: Biontech is working on over twenty drugs against cancer. The doctor and fund ...
wiwo.de/unternehmen/industrie/biontech-das-wuerde-ein-neues-zeitalter-in-der-krebstherapie-einleiten/29750834.html
Quick Glance: Innovative Cancer Therapy: Biontech's Advancement
- Biontech is actively developing over twenty cancer medications with promising results.
- Current developments and potential market introductions of cancer treatments.
- Significance of Biontech's promising results against pancreatic cancer.
Starting signal for the new TRON building in Mainz's upper town: A lot of celebrities come to the groundbreaking ceremony for the important new research building ...
allgemeine-zeitung.de/lokales/mainz/stadt-mainz/startsignal-fuer-tron-neubau-in-der-mainzer-oberstadt-3477507
Quick Glance: TRON New Building in Mainz Oberstadt
- Prominent figures gather for the symbolic groundbreaking of TRON gGmbH's research building in Mainz.
- The new building with 10,800 square meters is expected to be completed by 2027 to enhance scientific goals.
- TRON plans to consolidate employees at one location, expand research with a focus on cutting-edge research.
- Co-founder Ugur Sahin's vision aims to integrate basic research and medicine, establishing TRON for the long term.
Better than BioNTech or Moderna? This share has been beating the market for years - can it do it again?
boerse-online.de/nachrichten/aktien/besser-als-biontech-oder-moderna-diese-aktie-schlaegt-den-markt-seit-jahren-kann-sie-das-wieder-20355498.html
Breakthrough in cancer treatment? New data makes doctors euphoric: Could cancer soon be curable? A certain vaccine is showing initial positive effects in ...
infranken.de/ratgeber/gesundheit/durchbruch-in-der-krebsbehandlung-neue-daten-machen-mediziner-euphorisch-art-5855650
Red numbers after the boom: This is what Mainz's finances look like: After the Biontech boom, the Mainz budget slipped significantly into the red for the second ...
allgemeine-zeitung.de/lokales/mainz/stadt-mainz/rote-zahlen-nach-dem-boom-so-sehen-die-mainzer-finanzen-aus-3492267
Pfizer wins pause on Moderna's COVID-19 patent lawsuit: Moderna's patent lawsuit claiming Pfizer and BioNTech copied its COVID-19 vaccine technology will be put ...
reuters.com/legal/litigation/pfizer-wins-pause-modernas-covid-19-patent-lawsuit-2024-04-12/
Biontech is probably in the red this year: Biontech could end a financial year with losses in 2024 for the first time since the pandemic ...
wiesbadener-kurier.de/wirtschaft/wirtschaft-hessen-und-rheinland-pfalz/biontech-schreibt-dieses-jahr-wohl-rote-zahlen-3464126
Quick Glance: Biontech: Financial Situation and Product Portfolio
- Biontech is expected to slip into the red this year. Indications suggest that losses will be incurred.
- Biontech launched an immunization campaign half a year ago in Mainz with posters encouraging medical consultation.
- The company holds product aces, including vaccines and treatments combating diseases.
- The financial status reflects predicted losses despite an array of promising products.
Eli Lilly: billions invested in the pharmaceutical industry: Eli Lilly and other pharmaceutical companies are investing a lot of money in Germany. Why ...
sueddeutsche.de/wirtschaft/medikamente-eli-lilly-wacker-chemie-biontech-investitionen-vfa-deindustrialisierung-1.6531745
Paid articlePaid
Medicine and research: Why so many companies are investing in RNA technology: The three letters RNA represent a revolution in medicine. Companies from the ...
faz.net/aktuell/rhein-main/warum-so-viele-unternehmen-in-rna-investieren-19625909.html
Paid articlePaid
Vaccine deal with Pfizer: Ursula von der Leyen in the sights of corruption hunters
rundschau-online.de/red/impfstoff-deal-mit-pfizer-von-der-leyen-im-visier-der-korruptionsjaeger-770493
After Boehringer and Lilly, the Chancellor is now also visiting Merck: First Biontech, then Boehringer, Lilly in Alzey, now Merck in Darmstadt and the BKA in ...
allgemeine-zeitung.de/wirtschaft/wirtschaft-hessen-und-rheinland-pfalz/nach-boehringer-und-lilly-besucht-der-kanzler-nun-auch-merck-3514944
For two years, income in Mainz was bubbling. But the trade tax boom is over - and Biontech could end a financial year with losses in 2024 ... Show more www.allgemeine-zeitung.de/lokales/mainz/stadt-mainz/mainz-nach-dem-boom-zu-viele-ausgaben-und-projekte-3405908
Eli Lilly, Biontech and Co: Where the country should make improvements: Are science and the economy in Rhineland-Palatinate doing well or badly? The members of ...
allgemeine-zeitung.de/politik/politik-rheinland-pfalz/eli-lilly-biontech-und-co-wo-das-land-nachbessern-soll-3491494
Stock exchange: It takes more than just TUI: TUI returns to the German stock exchange. But that alone hardly helps the capital market in this country.
faz.net/aktuell/wirtschaft/es-braucht-mehr-als-nur-tui-19639524.html
mRNA pioneer: Biontech focuses on cancer therapies: The Mainz mRNA pioneer is doing well in the declining Corona business. However, the focus is clearly on the ...
faz.net/aktuell/wirtschaft/unternehmen/biontech-fokussiert-auf-krebstherapien-19599944.html
Quick Glance: BioNTech Focuses on Cancer Drug Development after Revenue Plunge
- BioNTech reported a significant drop in revenue and earnings in 2023 as it shifts focus towards cancer drug development.
- The company aims for revenues between 2.5 billion to 3.1 billion euros in 2024.
- BioNTech plans to launch its first oncology drug in 2026 and secure ten indication approvals by 2030.
- Partner Pfizer anticipates a decline in sales for the COVID-19 vaccine, while BioNTech invests in scaling up its oncology business.
Biontech's business collapses massively: buy shares cheaply now?: Corona is over, and the numbers and share price at vaccine manufacturer Biontech are collapsing ...
capital.de/geld-versicherungen/biontechs-geschaeft-bricht-massiv-ein--aktie-jetzt-guenstig-kaufen--34561014.html
Paid articlePaidQuick Glance: Biontech: Massive Business Decline Post-COVID
- As COVID ends, Biontech faces declining numbers and stock prices.
- A study reveals the significant impact of COVID on life expectancy.
- Biontech gained global recognition with the mRNA vaccine.
- The company is now focusing on new treatments for cancer to bounce back.
Does she know more? Star investor Cathie Wood has just signed up for this BioNTech competitor
boerse-online.de/nachrichten/aktien/weiss-sie-mehr-bei-diesem-biontech-konkurrent-hat-cathie-wood-gerade-zugeschlagen-20353621.html
BioNTech gets US agency notice over default on COVID vaccine royalties: BioNTech said on Monday the U.S. National Institutes of Health has sent a notice to the ...
reuters.com/business/healthcare-pharmaceuticals/biontech-gets-us-agency-notice-over-default-covid-vaccine-royalties-2024-03-25/
Sick after coronavirus vaccination? Palatinate man goes to court: A man from Pirmasens takes Biontech to court. Because he has suffered serious damage to his ...
rheinpfalz.de/lokal/pirmasens_artikel,-krank-nach-corona-impfung-pf%C3%A4lzer-zieht-vor-gericht-_arid,5628342.html
RKI doubted AstraZeneca for months: “Less perfect”, “not a sure-fire success”, “2-class vaccination”
fr.de/politik/rki-protokolle-robert-koch-institut-corona-coronavirus-impfung-astrazeneca-zr-92921607.html
If tech runs out of steam: That's why stocks from BioNTech and Co. are also exciting for investors
boerse-online.de/nachrichten/zertifikate/falls-tech-die-luft-ausgeht-darum-sind-auch-aktien-von-biontech-und-co-fuer-anleger-spannend-20353073.html
Munich: Major Biontech shareholders buy “Fünf Höfe” - for almost 800 million euros
sueddeutsche.de/muenchen/muenchen-fuenf-hoefe-verkauf-biontech-grossaktionaere-1.6472720
Biontech competitor Curevac cuts jobs in the region: High losses and a stock market crash: Curevac shows what could have happened to Biontech if the Mainz-based ...
wiesbadener-kurier.de/wirtschaft/wirtschaft-hessen-und-rheinland-pfalz/biontech-konkurrent-curevac-baut-stellen-in-der-region-ab-3428188
Günter Beck presents the supplementary budget for 2024 to the Mainz city council. After the Biontech boom, a deficit of 89 million is now expected ... Show more www.allgemeine-zeitung.de/lokales/mainz/stadt-mainz/grosses-mainzer-minus-kurskorrektur-alternativlos-3386683
After "golden years" for Idar-Oberstein: where have the millions gone?: Idar-Oberstein. Where have the Biontech millions gone? Where have they gone? Why is ...
rhein-zeitung.de/region/aus-den-lokalredaktionen/nahe-zeitung_artikel,-nach-goldenen-jahren-fuer-idaroberstein-wo-sind-die-millionen-hin-_arid,2629992.html
Paid articlePaid
Large traditional companies like Miele are moving their production abroad. Energy costs, bureaucracy and poor infrastructure ... Show more s.focus.de/Wirtschaft-Entwicklungsland
COVID-19 timeline: How the deadly virus and the world's response have evolved over 4 years
abcnews.go.com/Health/covid-19-timeline-deadly-virus-worlds-response-evolved/story
With AI against cancer: How Biontech wants to make medical history for the second time
spiegel.de/wirtschaft/mit-ki-gegen-krebs-wie-biontech-zum-zweiten-mal-medizingeschichte-schreiben-will-a-49e25377-fe41-4e5a-8706-5272f27ee47d
Paid articlePaid Mega potential: Will this biotech stock be as big as BioNTech and Moderna in their heyday?
boerse-online.de/nachrichten/aktien/mega-potenzial-wird-diese-biotech-aktie-so-gross-wie-biontech-und-moderna-zu-ihren-besten-zeiten--20354243.html
Frankfurt Regional Court: Action against Biontech for alleged vaccination damage dismissed
faz.net/aktuell/rhein-main/landgericht-frankfurt-klage-gegen-biontech-wegen-angeblicher-impfschaeden-abgewiesen-19518762.html
Quick Glance: Lawsuit against Biontech Dismissed
- Woman sought 150,000 euros in damages from Biontech.
- Court rejects lawsuit over alleged vaccine injuries.
- Plaintiff claimed heart damage from vaccination.
- Landgericht Frankfurt rules against damages claim.
Marburg special fund: bonds and shares for residential construction: The university city of Marburg has invested 350 million euros from business taxes in a ...
faz.net/aktuell/rhein-main/fuer-wohnungsbau-marburg-investiert-biontech-millionen-in-aktien-19517164.html
Paid articlePaidQuick Glance: Marburg Invests Biontech Millions in Stocks
- The university town of Marburg invests 350 million euros from business taxes into a special fund.
- The city aims to prevent a situation like Greensill's collapse with its approved approach.
- Mayor Spies acknowledges that the city must bear the risk of stock fluctuations.
- The city plans to invest 500 million euros in infrastructure over the coming years, including schools, housing, roads, and climate protection.
Poor share price: Lawyers call for an attack on Biontech: A new wave of lawsuits is threatening in the USA: nine large law firms have filed class action lawsuits ...
wiesbadener-kurier.de/wirtschaft/wirtschaft-hessen-und-rheinland-pfalz/mieser-aktienkurs-anwaelte-blasen-zum-angriff-auf-biontech-3319219
Moderna shares: Something is on the horizon here: Moderna Stock Approaches Key Resistance.
deraktionaer.de/artikel/pharma-biotech/moderna-aktie-hier-bahnt-sich-etwas-an-20353823.html
NYC students' vaccination rates still below pre-pandemic levels: Health Dept: In the city’s public and charter schools, 95.3% of students are up to date with ...
nypost.com/2024/03/02/us-news/nyc-students-vaccination-rates-still-below-pre-pandemic-levels-health-dept/
This Vaccine Maker Sits on Cash Almost Equal to Its Market Value: BioNTech partnered with Pfizer in the leading Covid vaccine, but sales have slid in recent ...
barrons.com/articles/biontech-cash-market-value-6ce8027e
Paid articlePaid Lauterbach's plan: a federal commission for medical ethics: Chancellor Scholz wants a "German pace" in the approval of clinical trials, Minister Lauterbach is ...
faz.net/aktuell/wissen/medizin-ernaehrung/kritik-an-plan-von-gesundheitsminister-lauterbach-fuer-ethikkommission-19524066.html
Boots customers who are aged '12 and over' face £98 charge from next week: The pharmacy has announced it will offer Pfizer/BioNTech vaccine to those not eligible ...
birminghammail.co.uk/news/cost-of-living/boots-customers-who-aged-12-28891825
Anyone who wants to become a senior national player should practice early! Our two young #Zebras #Yavuz & #Inanoglu are currently with the Turkish #U19 on the road ... Show more www.msv-duisburg.de/aktuelles/artikel/msv-international-inanoglu-yavuz-auf-em-kurs/ #WeilDUesBist
BioNTech SE (BNTX) Q4 2023 Earnings Call Transcript: BioNTech SE (NASDAQ:NASDAQ:BNTX) Q4 2023 Earnings Conference Call March 20, 2024 8:00 AM ETCompany ...
seekingalpha.com/article/4679436-biontech-se-bntx-q4-2023-earnings-call-transcript
Is the next BioNTech coming here? That's why analysts are currently hyping this unknown biotech stock
boerse-online.de/nachrichten/aktien/kommt-hier-das-naechste-biontech-darum-hypen-analysten-derzeit-diese-unbekannte-biotech-aktie-20350824.html
“Görzhausen IV”: This is how Marburg’s political exchange of blows with the trade went
op-marburg.de/lokales/marburg-biedenkopf/marburg/goerzhausen-iv-so-lief-marburgs-politischer-schlagabtausch-zum-gewerbe-PCUGCRIZ3FFCPOXDQFHR4VOBGE.html
Paid articlePaid
Older Americans advised to get another Covid shot this spring: Most Covid-19 deaths and hospitalizations last year were among people 65 years and older.
freemalaysiatoday.com/category/world/2024/02/29/older-americans-advised-to-get-another-covid-shot-this-spring/
Cancer drugs: Japanese company Daiichi-Sankyo invests one billion euros in Germany
handelsblatt.com/unternehmen/industrie/krebsmedikamente-japanischer-konzerndaiichi-sankyo-investiert-eine-milliarde-euro-in-deutschland/100013083.html
How the Nobel Prize winner in medicine received a moving audience with the Pontiff and which important committee of scientists in the Holy See she was ... Show more www.allgemeine-zeitung.de/wirtschaft/wirtschaft-deutschland/papst-franziskus-ehrt-ex-biontech-forscherin-katalin-kariko-3313527
Börsenwoche: Does BEAU7Y help against transience?: The stock exchanges have found their messiah in Nvidia and its boss Jensen Huang. But what's going on with his ...
faz.net/aktuell/finanzen/boersenwoche-hilft-beau7y-gegen-vergaenglichkeit-19604722.html
BioNTech's Brew: Mixing COVID Legacy With Oncology Ambitions: BioNTech's (BNTX) Q4 earnings shows a significant revenue drop and profitability concerns ...
seekingalpha.com/article/4679447-biontech-brew-mixing-covid-legacy-oncology-ambitions
Paid articlePaid Flash update Wall Street: Eagerly waiting for the Fed - Boeing, Intel, BioNTech, Nasdaq and Mobileye in focus
deraktionaer.de/artikel/maerkte-forex-zinsen/blitz-update-wall-street-gespanntes-warten-auf-die-fed-boeing-intel-biontech-nasdaq-und-mobileye-im-fokus-20353426.html
BioNTech Earnings Fall Short of Estimates. The Stock Is Down.
barrons.com/articles/biontech-earnings-stock-price-e9769cf0
Paid articlePaid
COVID-19: No increased risk of stroke after bivalent booster: Silver Spring/Maryland - The suspicion that vaccination with the bivalent booster of the mRNA ...
aerzteblatt.de/nachrichten/150118/COVID-19-Kein-erhoehtes-Schlaganfallrisiko-nach-bivalentem-Booster
Covid jab to be sold in UK high street pharmacies: The Pfizer/BioNTech jab, which is suitable for people aged 12 and over, will be sold in pharmacies and private ...
standard.co.uk/news/health/covid-vaccine-buy-uk-pharmacy-boots-pfizer-biontech-b1138221.html
DAX: US interest rate decision, Bitcoin, Vonovia, Dt. Wohnen, Redcare, BioNTech, Adidas and BASF in focus
deraktionaer.de/artikel/indizes/dax-us-zinsentscheid-bitcoin-vonovia-dt-wohnen-redcare-biontech-adidas-und-basf-im-fokus-20353344.html
Like Pfizer and BioNTech, the biotechnology company Moderna is struggling with the post-corona period. Investors should be prepared for uncomfortable quarterly ... Show more ow.ly/81PF50QyO1n
German biotechs: CureVac hits the brakes, BioNTech faces an important date: CureVac plans to cut 150 jobs to focus on broader product pipeline.
deraktionaer.de/artikel/pharma-biotech/deutsche-biotechs-curevac-tritt-auf-die-bremse-biontech-vor-wichtigem-termin-20353214.html
Corona vaccination damage: Frankfurt regional court dismisses lawsuit against Biontech
allgemeine-zeitung.de/politik/politik-deutschland/corona-impfschaden-landgericht-frankfurt-weist-klage-ab-3313550
BioNTech is back: Save two important dates: BioNTech Stock Rises Over 5% After Announcement to Present Clinical Data at AACR Annual Meeting.
deraktionaer.de/artikel/pharma-biotech/biontech-meldet-sich-zurueck-zwei-wichtige-termine-vormerken-20352711.html
Moderna shares accelerate: That's the reason: That inspires you to start the week.
deraktionaer.de/artikel/pharma-biotech/moderna-aktie-gibt-maechtig-gas-das-ist-der-grund-20352636.html
Biontech Christmas party at the Citadel becomes an issue again: After Biontech's internal Citadel Christmas party in December, the topic came up again in the ...
allgemeine-zeitung.de/lokales/mainz/stadt-mainz/biontech-weihnachtsfeier-auf-zitadelle-wird-erneut-zum-thema-3269668
Man vaccinated for COVID 217 times reports no side effects: scientists: PARIS, France (AFP) — A German man who deliberately got vaccinated for COVID-19 217 times ...
jamaicaobserver.com/2024/03/06/man-vaccinated-covid-217-times-reports-no-side-effects-scientists/
Suspected corona vaccination damage: lawsuit against Biontech - 50,000 euros in compensation demanded
mz.de/lokal/aschersleben/mutmassliche-corona-impfschaeden-klage-gegen-biontech-50-000-euro-schmerzensgeld-3780920
Paid articlePaid Dividend ace at a bargain price? Here's why investors shouldn't write off this biotech stock
boerse-online.de/nachrichten/aktien/dividenden-ass-zum-schnaeppchenpreis-darum-sollten-anleger-diese-biotech-aktie-nicht-abschreiben--20352134.html
Wendy Williams' Aphasia Diagnosis Sparks Vaccine Conspiracy Theories: Williams' medical team this week announced that the TV personality has been diagnosed with ...
newsweek.com/wendy-williams-aphasia-dementia-covid19-vaccine-conspiracy-theories-twitter-x-1872716
Hamburg doctors see breakthrough in anti-cancer syringe: Biontech's coronavirus vaccine is being prepared for a syringe in a doctor's surgery in Hamburg (archive ...
abendblatt.de/hamburg/politik/article241761192/Hamburger-Aerzte-sehen-Durchbruch-bei-Spritze-gegen-Krebs.html
Paid articlePaid
Guyana gets more Pfizer vaccines, 1,000 Paxlovid doses from US to tackle COVID-19 - Guyana Chronicle
guyanachronicle.com/2024/02/22/guyana-gets-more-pfizer-vaccines-1000-paxlovid-doses-from-us-to-tackle-covid-19/
Koblenz regional court dismisses claim for damages due to corona vaccination: Koblenz - The regional court in Koblenz, Rhineland-Palatinate, has dismissed a ...
aerzteblatt.de/nachrichten/149517/Landgericht-Koblenz-weist-Schadenersatzklage-wegen-Coronaimpfung-ab
Switching arms for vaccines could help boost your immunity, study finds: A new study examines whether alternating arms for multidose vaccines could improve ...
medicalnewstoday.com/articles/alternating-arms-for-vaccines-may-boost-immunity
Aaron Rodgers tells Joe Rogan he's lost friends, allies, millions over his COVID-19 beliefs
usatoday.com/story/sports/nfl/2024/02/07/aaron-rodgers-joe-rogan-covid-19/72517888007/
Two of our Zebra talents, Emre Çil (U19) and Uğur Şahin (U17), are currently with their respective Turkish junior national teams ... Show more #WeilDUesBist
BioNTech: Exciting cooperation - Stock is rising: BioNTech partners with Autolus to develop CAR T-cell therapies against cancer.
deraktionaer.de/artikel/pharma-biotech/biontech-spannende-kooperation-aktie-zieht-an-20349999.html
Vaccine Life Hack: Use Both Arms: New research finds that getting vaccinated in both arms can boost your immune response to covid-19 and possibly other diseases.
gizmodo.com/vaccine-life-hack-use-both-arms-1851231749
With AI against cancer: How Biontech wants to make medical history for the second time
spiegel.de/wirtschaft/mit-ki-gegen-krebs-wie-biontech-zum-zweiten-mal-medizingeschichte-schreiben-will-a-49e25377-fe41-4e5a-8706-5272f27ee47d
Paid articlePaid The new SPIEGEL is here!
Once a diagnosis was often a death sentence, but groundbreaking research advances are transforming cancer treatment ... Show more www.spiegel.de/spiegel/print/index-2024-6.html
Alleged vaccine damage: First proceedings opened in Hesse against Biontech: Vaccinated people all over Germany are suing pharmaceutical companies because of ...
faz.net/aktuell/rhein-main/frankfurt/corona-impfungen-verfahren-gegen-biontech-wegen-vermeintlicher-impfschaeden-19469214.html
Paid articlePaidQuick Glance: Lawsuit Against Biontech for Alleged Vaccine Injuries
- Vaccinated individuals across Germany are suing pharmaceutical companies for alleged vaccine injuries.
- The first lawsuit against Biontech in Hessen has commenced in Frankfurt.
- The Frankfurt Regional Court heard a civil lawsuit against vaccine manufacturer Biontech on Tuesday.
- Lawyers represent nearly 3000 cases of alleged vaccine injuries and lawsuits.
Pharmaceutical industry: How Germany has lost its mRNA advantage: Thanks to Biontech and Curevac, Germany considers itself to be at the forefront of mRNA ...
faz.net/aktuell/wirtschaft/pharmabranche-deutschland-hat-seinen-mrna-vorteil-verspielt-19492470.html
Paid articlePaid
BioNTech co-founder Christoph Huber: “Threat was stylized instead of clarified” | Tyrolean daily newspaper online
tt.com/artikel/30874945/biontech-mitgruender-christoph-huber-bedrohung-wurde-stilisiert-statt-aufzuklaeren
Comirnaty BA.4-5 no longer available from March 1st: Berlin - The COVID-19 vaccine Corminaty from the manufacturer Biontech/Pfizer, which is adapted to the ...
aerzteblatt.de/nachrichten/149045/Comirnaty-BA-4-5-ab-1-Maerz-nicht-mehr-verfuegbar
New to NewsWall?
Sign up now to get your own personalized news!
Trending topics